Researchers from the UK have reported that survivors of childhood cancer are 18 times more likely to develop thyroid cancer than the general population. The details of this study appeared in the November 15, 2009 issue of the International Journal of Cancer.[1]
Survivors of childhood cancers are often at risk for long-term and late effects of cancer and its treatment. This includes the development of second cancers later in life, often as a result of exposure to radiation therapy. Researchers associated with the Childhood Cancer Survivor Study have previously reported that survivors of childhood cancer who had received radiation therapy to the neck had a dose-related increased risk of thyroid cancer.
The British Childhood Cancer Survivor Study was designed to monitor the late effects of treatment in childhood cancer survivors and includes 17,980 survivors of childhood cancer who had been diagnosed between 1940 and 1991 and had survived at least five years. After a median follow-up of 17.4 years per survivor, these researchers identified 50 cases of thyroid cancer compared with an estimated 2.8 cases for the general population. Eighty-eight percent of patients who developed thyroid cancer had received radiation therapy near the thyroid gland. Survivors of Hodgkin’s disease and non-Hodgkin’s lymphoma appeared to be at the greatest risk of developing thyroid cancer. Survivors who had been treated with radiation were more than four times as likely to develop thyroid cancer compared with those who were not treated with radiation.
Comments: These researchers concluded that childhood cancer survivors are at a high risk of developing thyroid cancer, especially if they receive radiation in or around the thyroid area.
Reference:
[1] Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: Results from the British Childhood Cancer Survivor Study. International Journal of Cancer. 2009; 125: 2400-2405.
© 1998-2007 OncoEd.com All Rights Reserved.
These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers should verify all information and data before administering any drug, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.